Double blind trial of nicotinamide in recent-onset IDDM (the IMDIAB III study).
Pozzilli P, Visalli N, Signore A, Baroni MG, Buzzetti R, Cavallo MG, Boccuni ML, Fava D, Gragnoli C, Andreani D, et al.
Pozzilli P, et al.
Diabetologia. 1995 Jul;38(7):848-52. doi: 10.1007/s001250050362.
Diabetologia. 1995.
PMID: 7556988
Clinical Trial.